China SXT Pharmaceuticals, Inc. - Common Stock (SXTC)
0.1510
-1.0990 (-87.92%)
NASDAQ · Last Trade: Jan 10th, 3:59 AM EST
Detailed Quote
Previous Close
1.250
Open
1.440
Bid
0.1621
Ask
0.1624
Day's Range
0.1420 - 1.460
52 Week Range
0.1420 - 6.980
Volume
113,038,664
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
10,558,363
Chart
About China SXT Pharmaceuticals, Inc. - Common Stock (SXTC)
China Sxt Pharmaceuticals Inc is a pharmaceutical company that focuses on the development, manufacturing, and marketing of traditional Chinese medicine products. The company aims to harness the therapeutic potential of herbal formulas and integrative approaches to health, catering to both domestic and international markets. With a commitment to innovation, China Sxt Pharmaceuticals combines traditional medical practices with modern pharmaceutical techniques to enhance the efficacy and safety of its products, while also working to expand its portfolio and distribution channels within the healthcare sector. Read More
TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase and sale of an aggregate of 66,666,666 Class A ordinary shares of the company, no par value per share (the “Shares”) (or pre-funded warrants in lieu thereof), at a purchase price of $0.15 per share in a registered direct offering. The purchase price for each pre-funded warrant is identical to the purchase price for each Share, less the exercise price of $0.001 per share.
Roadzen Inc. (NASDAQ: RDZN) is taking a decisive step toward redefining the global auto insurance and claims ecosystem with its strategic acquisition of VehicleCare, unveiled at CES 2026. The deal meaningfully expands Roadzen’s scope from AI-driven claims intelligence into on-ground repair execution , creating a full-stack, end-to-end motor claims operating system.
Roadzen Inc. (NASDAQ: RDZN) is taking a decisive step toward redefining the global auto insurance and claims ecosystem with its strategic acquisition of VehicleCare, unveiled at CES 2026. The deal meaningfully expands Roadzen’s scope from AI-driven claims intelligence into on-ground repair execution , creating a full-stack, end-to-end motor claims operating system.
TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced the launch of a Strategic Artificial Intelligence (AI) Insights Initiative. This initiative aims to integrate AI-driven analytics into the Company’s product portfolio planning and market intelligence processes, further strengthening its long-term strategy to evolve into a data-informed and innovation-driven modern TCM enterprise.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
